441 related articles for article (PubMed ID: 21646482)
1. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.
Arroyo LA; Herrera CM; Fernandez L; Hankins JV; Trent MS; Hancock RE
Antimicrob Agents Chemother; 2011 Aug; 55(8):3743-51. PubMed ID: 21646482
[TBL] [Abstract][Full Text] [Related]
2. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.
Beceiro A; Llobet E; Aranda J; Bengoechea JA; Doumith M; Hornsey M; Dhanji H; Chart H; Bou G; Livermore DM; Woodford N
Antimicrob Agents Chemother; 2011 Jul; 55(7):3370-9. PubMed ID: 21576434
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
Haeili M; Kafshdouz M; Feizabadi MM
Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.
El Mrimar N; Belouad EM; Benaissa E; Bssaibis F; Jazouli M; El Alaoui MA; Maleb A; Elouennass M
Acta Microbiol Immunol Hung; 2024 Jul; 71(2):134-139. PubMed ID: 38837239
[TBL] [Abstract][Full Text] [Related]
5. Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii.
Charretier Y; Diene SM; Baud D; Chatellier S; Santiago-Allexant E; van Belkum A; Guigon G; Schrenzel J
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914966
[TBL] [Abstract][Full Text] [Related]
6. Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS.
Deveson Lucas D; Crane B; Wright A; Han ML; Moffatt J; Bulach D; Gladman SL; Powell D; Aranda J; Seemann T; Machado D; Pacheco T; Marques T; Viveiros M; Nation R; Li J; Harper M; Boyce JD
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712662
[TBL] [Abstract][Full Text] [Related]
7. A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii.
Chin CY; Gregg KA; Napier BA; Ernst RK; Weiss DS
Antimicrob Agents Chemother; 2015 Dec; 59(12):7911-4. PubMed ID: 26459891
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Novel
Gerson S; Betts JW; Lucaßen K; Nodari CS; Wille J; Josten M; Göttig S; Nowak J; Stefanik D; Roca I; Vila J; Cisneros JM; La Ragione RM; Seifert H; Higgins PG
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617096
[TBL] [Abstract][Full Text] [Related]
9. The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica.
Lee H; Hsu FF; Turk J; Groisman EA
J Bacteriol; 2004 Jul; 186(13):4124-33. PubMed ID: 15205413
[TBL] [Abstract][Full Text] [Related]
10. Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.
Maifiah MH; Cheah SE; Johnson MD; Han ML; Boyce JD; Thamlikitkul V; Forrest A; Kaye KS; Hertzog P; Purcell AW; Song J; Velkov T; Creek DJ; Li J
Sci Rep; 2016 Feb; 6():22287. PubMed ID: 26924392
[TBL] [Abstract][Full Text] [Related]
11. pmrA(Con) confers pmrHFIJKL-dependent EGTA and polymyxin resistance on msbB Salmonella by decorating lipid A with phosphoethanolamine.
Murray SR; Ernst RK; Bermudes D; Miller SI; Low KB
J Bacteriol; 2007 Jul; 189(14):5161-9. PubMed ID: 17449614
[TBL] [Abstract][Full Text] [Related]
12. Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates.
Girardello R; Visconde M; Cayô R; Figueiredo RC; Mori MA; Lincopan N; Gales AC
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):37-44. PubMed ID: 27776788
[TBL] [Abstract][Full Text] [Related]
13. Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat.
Lima WG; Alves MC; Cruz WS; Paiva MC
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1009-1019. PubMed ID: 29524060
[TBL] [Abstract][Full Text] [Related]
14. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
Gerson S; Lucaßen K; Wille J; Nodari CS; Stefanik D; Nowak J; Wille T; Betts JW; Roca I; Vila J; Cisneros JM; Seifert H; Higgins PG
Int J Antimicrob Agents; 2020 Mar; 55(3):105862. PubMed ID: 31837449
[TBL] [Abstract][Full Text] [Related]
15. The pmrF polymyxin-resistance operon of Yersinia pseudotuberculosis is upregulated by the PhoP-PhoQ two-component system but not by PmrA-PmrB, and is not required for virulence.
Marceau M; Sebbane F; Ewann F; Collyn F; Lindner B; Campos MA; Bengoechea JA; Simonet M
Microbiology (Reading); 2004 Dec; 150(Pt 12):3947-57. PubMed ID: 15583148
[TBL] [Abstract][Full Text] [Related]
16. Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens.
Cheah SE; Johnson MD; Zhu Y; Tsuji BT; Forrest A; Bulitta JB; Boyce JD; Nation RL; Li J
Sci Rep; 2016 May; 6():26233. PubMed ID: 27195897
[TBL] [Abstract][Full Text] [Related]
17.
Nodari CS; Fuchs SA; Xanthopoulou K; Cayô R; Seifert H; Gales AC; Dilthey A; Higgins PG
mSphere; 2021 Dec; 6(6):e0074621. PubMed ID: 34851165
[TBL] [Abstract][Full Text] [Related]
18. Role of Salmonella enterica serovar Typhimurium two-component system PreA/PreB in modulating PmrA-regulated gene transcription.
Merighi M; Carroll-Portillo A; Septer AN; Bhatiya A; Gunn JS
J Bacteriol; 2006 Jan; 188(1):141-9. PubMed ID: 16352830
[TBL] [Abstract][Full Text] [Related]
19. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
[TBL] [Abstract][Full Text] [Related]
20. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
